CASS Pharmaceuticals
Franklin, US · Founded 2020 · Delaware corporation
Founders & leadership
SS
Solomon SteinerNamed on SEC filing
SM
Stephen McCormackNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2020–2022
▶$2MraisedOct 2022 · 6 investors · Other TechnologyRule 506(b)
▶$2MraisedOct 2022 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Solomon SteinerExecutive Officer, Director, Promoter
- Stephen McCormackExecutive Officer, Director, Promoter
- Offering amount
- $4.5M
- Amount sold
- $2M
- Proceeds to insiders
- $100K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$150KraisedSep 2020 · 1 investors · Other TechnologyRule 506(b)
▶$150KraisedSep 2020 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Solomon SteinerExecutive Officer, Director, Promoter
- Stephen McCormackExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $150K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CASS Pharmaceuticals raised?
- CASS Pharmaceuticals has disclosed $2.1M raised across 2 rounds.
- Where is CASS Pharmaceuticals headquartered?
- CASS Pharmaceuticals is headquartered in Franklin, US.